Fungal sensitisation in children with severe therapy resistant asthma

M. Maglione, S. Castanhinha, A. Gupta, S. Koo, C. Bossley, L. Fleming, A. Bush, S. Saglani (London, United Kingdom; Lisbon, Portugal; Naples, Italy; Hong Kong, China)

Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Session: Severe asthma and developing allergy in childhood
Session type: Oral Presentation
Number: 4711
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Maglione, S. Castanhinha, A. Gupta, S. Koo, C. Bossley, L. Fleming, A. Bush, S. Saglani (London, United Kingdom; Lisbon, Portugal; Naples, Italy; Hong Kong, China). Fungal sensitisation in children with severe therapy resistant asthma. Eur Respir J 2012; 40: Suppl. 56, 4711

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is fungal sensitisation associated with exacerbation-prone or severe preschool wheezing?
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Anti-IgE treatment in children with severe intrinsic asthma
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019


Prevalence of therapeutic resistant and steroid resistant bronchial asthma in children and adolescents
Source: Eur Respir J 2005; 26: Suppl. 49, 681s
Year: 2005

Novel therapies for severe asthma in children and adults
Source: Breathe, 14 (1) 59; 10.1183/20734735.018917
Year: 2018



The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017

Omalizumab is an effective intervention in severe asthma with aspergillus sensitisation.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Immunotherapy in severe asthma
Source: ERS webinar 2021: Immunotherapy in severe asthma
Year: 2021


Severe asthma in children
Source: CME Online 2011
Year: 2011

Severe asthma in children
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015



Aspergillus sensitization and aspergillus-associated diseases in a sample of patients with severe asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Omalizumab in children with severe persistent allergic asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Management of severe asthma in children
Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma
Year: 2010


ME11 Management of severe asthma in children
Source: Paris 2018 - Educational material
Year: 2018

Management of severe asthma in children
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020


Management of severe asthma in children
Source: International Congress 2018 – ME11 Management of severe asthma in children FULLY BOOKED
Year: 2018


Role of atypical bacterial infections in exacerbation of asthma in children
Source: Eur Respir J 2005; 26: Suppl. 49, 165s
Year: 2005

Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015

Improvement in asthma severity and control by voriconazole and posaconazole in severe asthma with fungal sensitization (SAFS) and ABPA
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012